Recombinant Antibodies Derived From Convalescent Whole Blood May Be the Answer to COVID-19

Laalithya Konduru

Research output: Contribution to journalLetterpeer-review

3 Downloads (Pure)

Abstract

As of 1st May 2020, the SARS-CoV-2 virus has affected 3,308,555 people all over the world, and caused 234,112 deaths. There are currently no vaccines and no specific therapeutic agents have been shown to be effective against COVID-19 caused by SARS-CoV-2 (1).
Original languageEnglish
Article numbere104463
Number of pages2
JournalInternational Journal of Infection
Volume7
Issue number2
DOIs
Publication statusPublished - Apr 2020

Keywords

  • Blood
  • COVID-19
  • Convalescent plasma
  • Antibodies

Fingerprint

Dive into the research topics of 'Recombinant Antibodies Derived From Convalescent Whole Blood May Be the Answer to COVID-19'. Together they form a unique fingerprint.

Cite this